What Is Your Corporate RNA?

What Is Your Corporate RNA?

What's Your Corporate RNA?

  Data-Driven Narrative for Capital Formation in Life Sciences The question “What is your corporate DNA?” has become ubiquitous in strategic discourse. Organizational theorists have operationalized this biological metaphor to describe the foundational elements – structure, decision rights, information flows, and incentive systems – that define an enterprise’s identity and drive its behavior. For biotechnology […]

Client Success: Healthcare Transaction Support to Assess Value from Different Perspectives

By Jeff Williamson THE SITUATION: A healthcare company with a portfolio of products in development for treating cardiac conditions was fielding investor interest for a potential acquisition. The company wanted to weigh the relative merits of raising additional equity financing versus exploring multiple M&A offers, as these initial discussions indicated a price range that did […]

Client Success: Strategic Extension for Revenue-Stage Medtech Company

By Jeff Williamson THE SITUATION: A medical device company was preparing to launch a novel product used in interventional cardiac surgeries — one that offered improved performance, simplified clinical workflows, and reduced procedure times. The company asked RNA to help it quantify the benefits of the new device in light of direct cost savings, workflow streamlining, […]

Client Success: Navigating Strategic Investment in Healthcare Technology

THE PROBLEM: A healthcare technology company that sells its FDA 510(k) approved device and supporting dashboarding and analytic tools to hospitals was in the midst of a capital raising effort involving a one-on-one negotiation with an existing strategic partner. The company received from the strategic partner a “low-ball” valuation. The company’s management team and board […]

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.